Docking and scoring in virtual screening for drug discovery: methods and applications

Area of Science:

• Computational chemistry and structural biology
• Drug discovery and medicinal chemistry

Background:

• Structure-based design and screening strategies, including molecular docking, are crucial in identifying and optimizing drug candidates.
• Successful drugs, such as HIV protease inhibitors, demonstrate the impact of these computational approaches.
• Current limitations persist, particularly concerning the accuracy and reliability of scoring schemes used in docking.

Purpose of the Study:

• To review fundamental concepts and specific features of small-molecule-protein docking methodologies.
• To highlight selected successful applications of docking in drug discovery.
• To discuss recent advancements aimed at overcoming the limitations of existing docking and scoring approaches.

Main Methods:

• Review of established computational molecular docking techniques.
• Analysis of scoring functions used to predict binding affinity and complementarity.
• Examination of structure-based drug design principles and their application.

Main Results:

• Molecular docking is a powerful tool for hit identification and lead optimization in drug development.
• Significant challenges remain in the precision of scoring schemes, impacting the prediction of binding interactions.
• Emerging methods show promise in enhancing the accuracy and applicability of docking strategies.

Conclusions:

• Computational docking remains a cornerstone of modern drug discovery, despite existing challenges.
• Continued research and development of advanced scoring functions are essential for improving prediction accuracy.
• Addressing the limitations of current methods will further enhance the utility of structure-based design in pharmaceutical research.